Raffles Medical Group Ltd (SGX: BSL)

Raffles Medical Group Income Statement

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	701.86	706.92	822.92	723.79	568.2	522.04
Other Revenue	1.11	1.11	2.03	1.44	-	-
Revenue	702.97	708.03	824.95	725.23	568.2	522.04
Revenue Growth (YoY)	-10.56%	-14.17%	13.75%	27.64%	8.84%	6.73%
Cost of Revenue	392.09	392.1	424.85	530.24	427.47	377.85
Gross Profit	310.88	315.94	400.1	194.99	140.73	144.19
Selling, General & Admin	162.4	142.02	109.2	5.44	5.38	8.38
Other Operating Expenses	40.96	32	41.22	34.22	30.23	33.71
Operating Expenses	238.04	207.76	186.83	76.79	69.67	70.15
Operating Income	72.85	108.18	213.26	118.2	71.07	74.04
Interest Expense	-6.52	-6.08	-6.85	-6.36	-5.15	-1.94
Interest & Investment Income	10.53	9.76	2.74	0.63	1.15	1.7
EBT Excluding Unusual Items	76.85	111.86	209.15	112.48	67.06	73.8
Impairment of Goodwill	-	-	-5.87	-3.78	-3.5	-
Asset Writedown	7.4	7.4	-12.03	0.41	-4.5	2.13
Other Unusual Items	0.18	0.18	0.08	6.47	25.38	-
Pretax Income	84.43	119.44	191.34	115.58	84.44	75.92
Income Tax Expense	22.82	28.35	47.94	31.87	19.77	15.4
Earnings From Continuing Operations	61.6	91.09	143.4	83.72	64.67	60.52
Minority Interest in Earnings	-0.66	-0.94	-0.19	0.46	1.22	-0.25
Net Income	60.94	90.15	143.21	84.17	65.89	60.27
Net Income to Common	60.94	90.15	143.21	84.17	65.89	60.27
Net Income Growth	-57.54%	-37.05%	70.15%	27.74%	9.32%	-15.18%
Shares Outstanding (Basic)	1,859	1,859	1,857	1,868	1,839	1,813
Shares Outstanding (Diluted)	1,877	1,869	1,866	1,876	1,840	1,816
Shares Change (YoY)	0.56%	0.12%	-0.54%	1.96%	1.35%	1.54%
EPS (Basic)	0.03	0.05	0.08	0.05	0.04	0.03
EPS (Diluted)	0.03	0.05	0.08	0.04	0.04	0.03
EPS Growth	-57.83%	-37.16%	70.82%	25.42%	7.83%	-16.37%
Free Cash Flow	74.46	168.79	171.21	110.17	74.27	15.06
Free Cash Flow Per Share	0.04	0.09	0.09	0.06	0.04	0.01
Dividend Per Share	0.024	0.024	0.038	0.018	0.025	0.025
Dividend Growth	-36.84%	-36.84%	111.11%	-28.00%	0%	0%
Gross Margin	44.22%	44.62%	48.50%	26.89%	24.77%	27.62%
Operating Margin	10.36%	15.28%	25.85%	16.30%	12.51%	14.18%
Profit Margin	8.67%	12.73%	17.36%	11.61%	11.60%	11.55%
Free Cash Flow Margin	10.59%	23.84%	20.75%	15.19%	13.07%	2.88%
EBITDA	97.26	132.89	239.72	143.3	94.23	93.85
EBITDA Margin	13.84%	18.77%	29.06%	19.76%	16.58%	17.98%
D&A For EBITDA	24.42	24.71	26.46	25.1	23.17	19.81
EBIT	72.85	108.18	213.26	118.2	71.07	74.04
EBIT Margin	10.36%	15.28%	25.85%	16.30%	12.51%	14.18%
Effective Tax Rate	27.03%	23.74%	25.05%	27.57%	23.41%	20.29%

Source: S&P Capital IQ. Standard template. Financial Sources.